Skip to main content

Advertisement

ADVERTISEMENT

News

Mirragen - ETS Wound Care 

https://clinicaltrials.gov/study/NCT06598241

A 20-patient pilot clinical trial will evaluate the use of borate-based bioactive glass fiber matrix (Mirragen) for treatment of DFUs with primary outcome of complete wound closure at 12 weeks. Not yet recruiting; estimated study completion is Oct 2025. clinicaltrials.gov

Advertisement

Advertisement

Advertisement